In the murine BC model, delivery of CCL2‐neutralizing antibody inhibited monocyte release from bone marrow, macrophage infiltration, and vascular infiltration, thereby reducing the formation of lung metastases.67 The gene discussed is CCL2; the disease is breast cancer.